Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported its third quarter 2025 earnings outcomes in the present day.
Gross sales elevated 7.2% year-over-year to $39 billion. Gross sales have been up 6.9% on a continuing foreign money foundation. The highest line outcomes mirrored gross sales progress within the US Retail Pharmacy and Worldwide segments.
Web loss was $175 million, or $0.20 per share, in comparison with web earnings of $344 million, or $0.40 per share, final yr. Adjusted EPS was $0.38, down 39.6% on a continuing foreign money foundation.
US Retail Pharmacy phase gross sales have been $30.7 billion, up 7.8% from the year-ago quarter.
Worldwide phase gross sales have been $6.2 billion, up 7.8% YoY.
US Healthcare phase gross sales have been $2.1 billion, barely down from final yr.
Given its pending acquisition by Sycamore Companions, WBA beforehand withdrew its steerage for fiscal yr 2025.
